The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...

A drugs gang who tried to flood North Wales with cocaine, heroin and ketamine from Merseyside have been jailed for more than ...